Summary In recent years, vagal nerve stimulation (VNS) has been proposed as a possible way to improve the control of refractory (partial and generalized) seizures. To date, however, there is no complete understanding of the underlying mechanism for this action nor are there any available guidelines or criteria for the selection of those candidates that might be most suitable for this kind of neuromodulating surgery.
Introduction
Pathological synchronization of cortical activity plays a major role in the generation of seizures. Because antiepileptic drugs are not always effective in counteracting neuronal hyper-excitability and pathological synchronization, there are about 30% of the epileptic patients who are not satisfactorily controlled by medical therapy. 1 Traditional epilepsy surgery, i.e. that kind of surgery aiming to the epileptogenic zone resection or deconnection, is unfortunately not able to control seizures in the case of every intractable epilepsy. In addition, side effects of this kind of surgery are not negligible. For this reason alternative surgical strategies aiming to modulate neuronal activity of deep brain areas has been suggested. Thalamic 2 and subthalamic 3 stimulation have been found to produce encouraging results, but the number of patients is small and the method is further limited by the need for very precise stereotactic method for electrodes implantation. 4 Further information will be needed to assess the suitability and safety of this therapeutic alternative.
In the 1990s, vagal nerve stimulation (VNS) was proposed as a therapeutic strategy for the control of seizure activity. Though the exact mechanism of this strategy continues to remain uncertain, there is evidence that suggests an involvement of synaptic and neuro-chemical mechanisms. 5, 6 Numerous data on animals suggest an antiepileptic effect of VNS. In cats it is known to produce different effects on EEG activity and on sleep patterns, depending on the stimulus parameters that are used. High frequency stimulation has been demonstrated to desynchronize cortical activity and a putative mechanism of afferent activation of the nucleus of the solitary tract and the ascending reticular system was suggested. [7] [8] [9] Electrical stimulation of the vagus nerve has been shown to abort induced seizure activity in dogs 10 and also in primates. 11 While in cats, it has been shown to delay amygdaloid kindling. 12 In rats, more recent data suggests that stimulation of the myelinated A-and B-fibers of the vagus nerve is able to suppress seizure activity. 13 Zagon and Kemeny proposed that neuronal excitability is reduced by a slow hyperpolarization of cortical pyramidal cells. 14 In man vagal nerve has afferent fibers from lungs, heart, aorta, gastrointestinal tract and aortic chemoreceptors, projecting to the nucleus tractus solitarius. From this nucleus there are polysynaptic projections to different structures of the posterior fossa, but even to the noradrenergic and serotonergic neuromodulatory system, through the locus coeruleus. This nucleus is the major source of norepinephrine, and its interactions with vagal nerve is probably relevant, considering the antiepileptic effect of this aminoacid. The nuclei of the vagal nerve are also connected with hypothalamus, dorsal raphe, nucleus ambigus, amygdala and thalamus (6, 15) .
Positron-emission tomography (PET) induced significant increase in CBF in right thalamus and right posterior gyri, in the hypothalami and in insular cortex From recent studies on f-MRI in depressed patients, who received VNS, show an immediate activation of the orbitofrontal region, insula and medial temporal lobe. 19 VNS at high frequency (20 Hz) is known to have a greater effect than slow frequency (5 Hz) 16 inducing changes in cerebral blood flow with significant increases being found in orbitofrontal gyri, entorhinal cortex and temporal pole, 17 and concomitant decreases have been found in the amygdala, hippocampus and posterior cyngulate gyrus. These structures, amygdala, hippocampus and posterior cyngulate gyrus, which are commonly involved in partial epilepsies, seem to have a reduction of synaptic activity during VNS, which may account for a lower probability of seizure onset in those areas (6) .
Studies on the induction of immunoreactivity of 'fos', nuclear labelled protein, that has been used during VNS of the rat brain, has produced results which suggest that an antiepileptic effect may be linked to an elevation of 'fos' protein in forebrain structures. 18 An increase of norepinephrine has also been shown to play a role in controlling seizures after VNS. To add even more complexity to an already complicated mechanistic understanding of VNS is the finding that this kind of neuromodulation also exerts an effect on major clinical depression. 19 The mechanism of action of VNS is still debated and under study, but we assume that it may be mediated by a decreased synchrony of synaptic cortical activity, mediated by the thalamus, by an intermittent synaptic activation in the insula and hypothalamus, and by intermittently decreased activity in amygdala, hippocampus, and other limbic components. Also the intermittent release of norepinephrine contributes to the antiepileptic effect of VNS (6) .
Interestingly, the vagal nerve stimulator is actually a device, developed and produced by Cyberonics Inc., that grew out of the intense research and development work that has been directed to the development of safe and effective cardiac pacemakers. It is programmable pulse generator, and the VNS is connected to bipolar electrodes that have been surgically positioned around the left vagus nerve. This procedure is a safe and easily tolerated surgical technique that has been used successfully in the treatment of both adults and children suffering from partial refractory epilepsy. 20, 21 Surgery is performed under general or local anaesthesia using a standardized technique that typically lasts 60-80 min. Patients are routinely discharged on either the day of surgery or the following day and, to date, there have been no reports of any significant complications using VNS.
The results on using VNS to control seizure frequency have been encouraging. In most reports that are found in the literature, almost 35% of patients treated had a reduction of more than 50% of seizures, and the percentage of responders increases in the first year of stimulation, reaching as high as 60%. 15, [22] [23] [24] The outcomes that have been reported are, however, quite variable. In the description of Morris et al. 25 fits are significantly lessened in 50-90% of patients. Binnie et al. 26 report a lower percentage of responders (35%), although there are indications that a selection factor may account for this significant difference. In children, however, the results appear to be even better, with the percentage of success reaching even higher than a 90% seizure reduction (in 23% of the children studied). 27 In all of these reports, there is a greater seizure reduction when the VNS is more prolonged. 23 The finding of better results in the first year of stimulation may be suggestive of progressive changes in stimulation setting, although the reason remains unclear.
A review of the literature on VNS provides not indication or suggestion of which are the best candidates for VNS. Typically, adults and children with partial refractory epilepsy, with or without secondarily generalization, and who are not candidates for resective epilepsy surgery have been the patients who have been referred for this procedure. And there has been little or no attention paid to the predictive value of the electroclinical ictal pattern that was involved.
For these reasons, we have therefore selected a group of 17 adult patients to be implanted for VNS. All of these patients had intractable partial epilepsy with falls found in 16 of these cases. In one case, the patient had partial complex seizures and secondarily generalized tonico-clonic morpheic seizures.
Falling seizures in partial epilepsies have different pathogenesis and an ictal onset. Many of them are observed in frontal epilepsies, although they can be observed also in temporal epilepsy, and they seem to be linked to a mechanism of secondary bilateral synchrony. 28 These seizures are very disabling and have a poor prognosis. On the basis of existing experimental evidence, VNS should be expected to interrupt the ictal diffusion and lead to a selective reduction of epileptic falls. Falling seizures can, however be very different. They may be myoclonic, tonic, tonico-postural, atonic at onset, and with different EEGraphic patterns.
Our purpose, therefore, was to try to identify the best candidates for the VNS implant and to verify the effectiveness of VNS on epileptic falls.
The results of this study present data on the EEG ictal onset site that arose as was the clinical outcome in these patients following VNS.
Methods
Seventeen adult patients (11 males and 6 females) with intractable epilepsy were selected to be part of this study (Table 1) . After receiving approval from our hospital's ethical committee, and over a 5 year period from October 1995 to October 2000, we began the process of implanting electrodes in these 17 patients. Each of these patients was then followed up over a period that ranged from 4 to 9 years. The mean age at the time of implantion was 34 years (range 21-52), the mean age at the time of the onset of epilepsy was 10 years (range from 3 months to 39 years), and the mean duration of the patient's illness was 24 years (range 11-41). Patients whose epilepsies were the result of either progressive neurological disorders or evolutive brain lesions were excluded from the study. We also excluded any patients who were suffering from any known gastric or cardiac illness.
We divided these patients into the following categories: 'symptomatic', of which there were eight cases (perinatal injury in four, cerebral malformation in one, low grade tumor in one, subarachnoid hemorrhage in one, cavernoma in one); 'unknown etiology', of which there were five patients; and as 'cryptogenic', of which there were four patients. This last category, 'cryptogenic', included patients who showed a normal neurologic examination and a normal MRI in contrast to the 'unknown etiology' group which showed a normal MRI but also neurological signs and symptoms.
In five patients, the neurological examination was normal while in five it disclosed focal neurological signs that in three were found to be associated to mental retardation. In five patients we found signs of mild to severe mental deterioration and in the remaining two patients mental retardation was found to be associated to behavioral disturbances. The mean number of basal monthly seizures was 83.8 (range 6.3-720 with a standard deviation of 171.7). This mean number excludes clusters, which we observed in 5 of the 17 patients. In all but two patients we observed, at least, two different seizure types. Only one of these patients experienced a brief aura of distress prior to some of his seizures. In the other 16 cases there was an immediate loss of contact that was followed by versive or motor phenomena or automatisms, and falling. A preoperative recording was obtainedeither in our Institute or elsewhere -for, at least, one seizure type from every patient in the study. In 12 of the patients we studied falling was EEGraphically recorded. Table 2 reports typical ictal patterns of our series.
Five patients received unsuccessful surgical treatment prior to the VNS implant: patient B03 had a lesionectomy 3 years before implant for an oligoastrocytoma that had no effect on seizure frequency; patient B04, who was operated on for a cerebral aneurysm and shunted for hydrocephalus at the age of 3 months, developed epilepsy shortly after; patient B09 underwent a left precentral cortectomy 3 years before VNS implant, after a thorough presurgical study that involved seizure recording with deep electrodes. This procedure had no effect on seizure frequency, patient B11 was surgically treated for epilepsy with a temporobasal posterior cortectomy 18 months before the VNS implant that had no effect on seizure frequency; and finally, patient B15 underwent right frontopolar and frontomesial cortectomy 3.5 years before implant without any therapeutic effect (Fig. 1) .
The other patients were either refused or excluded from epilepsy surgery for the following reasons: (1) their type of epilepsy could not be defined on the basis of the information that was available; (2) the presence of synchronous bifrontal ictal discharges in which there was no certain signs of lateralization; (3) due to ictal involvement VNS: outcome and electroclinical pattern 201 of motor area; (4) due to severe mental retardation or psychic disturbances; (5) because of bilateral or polymorphous seizure activity. VNS implantation was performed, under general anaesthesia, in the upper left chest region and the stimulating lead was attached to the left vagus nerve in the neck. The technique used to implant the pulse generator is similar to that which is routinely used in the implantation of cardiac pacemakers. Electrodes are placed around the left vagus nerve at the level below its branching into superior and inferior cervical cardiac rami. In no cases did we experience any complications following surgery and all patients were discharged from the hospital 24 h after the implantation procedure.
The only side effect of significance which was reported by all patients was that of a voice alteration during the 'on' period of stimulation. This appeared to be related to the intensity of current that was used and was usually present at the moment that there was an increase of current. Though all patients reported this effect it seems to have been well tolerated it well and, as the stimulation progressed this effect was clearly reduced. Three patients began to cough every time the output current was increased. This effect also faded out with the passage of time and repetition. In one patient with Lennox-Gastaut syndrome (LNS) we observed a fecal and urinary incontinence, associated with diarrhea, when the output current was increased. This disappeared when there was a reduction of the intensity of the output current.
We activated the generators 15 days after surgery and the patients were initially controlled at 15 day intervals. This was then increased to monthly intervals and then to 3 month intervals. As time passed, these controls would depend upon the clinical results we observed although they were always performed at least once every 6 months.
The standard stimulation paradigm was: Output current was progressively modified depending upon the clinical outcomes and the subjects tolerance. We did not use a magnet to activate an extra burst of stimulation at the time of the onset of seizures in our patients because no auras were reported (except in one case we encountered) and the duration was too short. In one patient, a family member did use the magnet when the seizure began, and this seizure, was shortened and less severe. In nine patients, we switched our standard paradigm of stimulation to rapid cycle parameters after a minimum of an 8 month interval after implantation, but when we did this we found no satisfactory results.
The Rapid cycle paradigm was:
Output current We maintained this rapid cycle paradigm in only three patients, while we were able to return to the 202 M. Casazza et al. Bifrontal and right temporal rapid activity; stereoeeg shows a very large involvement of right frontal region B16 Diffuse attenuation and fast activity followed by diffuse spikes B17 Diffuse sw or spike and waves standard stimulation paradigm--with an increase of output current, in five patients after 4-10 months post-implant period. One patient was not able to tolerate the VNS. He reported a marked increase in seizures after less than one month of stimulation at 1.5 milliampères (ma) that was accompanied by an unacceptable hoarseness. Wanting to discontinue stimulation, he refused to try VNS even when we suggested lowering output currents. We then removed the VNS system 5 months after its implantion.
Results
The rather long follow-up of our patients indicate a stable effect of VNS. The effect that we were able to reach with the best stimulation paradigm (normal or rapid cycle and with varying intensities) was sustained with the passage of time. Only one patient (B11) experienced anything that resembled a transitory benefit--an almost complete disappearance of falling seizures followed by a rapid relapse to the seizure frequency seen during the pre-implant period. We report our findings of seizure reduction in terms attaining stable stimulating conditions within a 6-9 months after surgery. When we encountered unsatisfactory results with a normal cycle that was taken to the highest tolerated intensity we would then typically switch the VNS to a rapid cycle using the same level of intensity we had been using. No significant differences were observed using these different stimulation paradigms. In four patients with cryptogenic partial epilepsy, we found a reduction of more than 50% of the total number of monthly seizures (Table 3 ). In three of these patients the ictal recording indicated initial changes in temporal regions. In all of these patients falling seizures were decreased and in three of them there was also a reduction in minor seizures.
In four other patients, three of whom symptomatic, a less than 50% reduction of seizures was observed; a significant reduction in falling seizures was found in only two of them. In three of these four patients the initial onset of seizures was found in the temporal region.
In three patients of the reported on in Table 4 , seizure activity did not change significantly after VNS. Two of these patients had symptomatic epilepsy, while in one patient seizures were of unknown etiology. The frontal area was involved by ictal discharge in two of these.
Three of the 'symptomatic' patients reported on in Table 4 experienced an exacerbation of seizure VNS: outcome and electroclinical pattern 203 frequency and in two of these patients the central area was involved in ictal discharge. In one case, however, the total number of seizures and the number of minor seizures increased, but there was a dramatic disappearance of falling seizures to the great satisfaction of the patient. We therefore considered this to be a 'good' outcome. In this particular case the onset of ictal activity was found to be in the temporal zone. Three of the patients described in Table 4 had a significant increase of total seizure frequency and of fallings after VNS. In these cases, the ictal onset was frontal, frontocentral or diffuse. In one of these patients there was a dramatic increase in the number of different seizures after VNS activation and the patient refused to allow the stimulation to continue.
The three patients with an electroclinical LNS showed no significant results from VNS.
The falling seizures of our patients were of different types. In most cases they were tonic, symmetric or asymmetric, tonico-postural or tonicoversive. In three patients, seizures could be described as atonic and as retropulsive in one patient. Of the 12 patients whose ictal EEG pattern we were able to record we found seven cases were to be focal: three showing an involvement of the temporal region; three showing an involvement of the frontal region and the remaining one patient showing an involvement of the centroparietal. In five cases, the onset was observed to be diffuse although in two patients it seemed to be more indicative of an initial involvement in the temporal and, then, in the frontal area. Table 5 shows the results of the effect of VNS on the outcome of falling seizures. It appears that retropulsive fallings are more reduced than tonicopostural seizures, although unfortunately, we do not have ictal recordings of all epileptic fallings. Nonetheless, the temporal region does appear to be involved and in most of the patients we found a reduced number of recorded falling seizures.
The follow-up data shown in Table 6 indicates that 5 of the 17 patients are still being treated with stimulation. In the group of responders, a second or third implantation was needed by three patients when the battery became depleted because of an increase in seizure frequency. Two 204 M. Casazza et al. 
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patients maintained an unexplainable effect even after battery depletion had occurred. Three patients did not feel their seizures significantly reduced, although their number decreased. So they refused a new implantation after battery depletion. In one of them VNS was explanted.
In one patient epilepsy greatly improved after chronic VNS, but there seemed to be an exacerbation of her behavioral disturbances: her psychiatric symptoms worsened and she, unfortunately, committed suicide.
In two patients without results battery depletion has occurred but the stimulator has thus far not been removed, while in two patients with bad results the VNS was removed. One patient that did not seem to respond to VNS also had a pancreatic carcinoma that led him to his death while VNS was still active. In one patient, VNS was discontinued because it seemed to have no effect. In two patients VNS is still on, but results are bad.
During the first year of stimulation, all anti-epilectic drugs (AEDs) were maintained at stable levels, except in the case of one non responder whose neurologist elected to increase the amount of levetiracetam being used.
In all the other cases, AEDs have been adjusted during VNS only after the first year and this was usually done by introducing new medications.
Discussion and conclusions
Vagal nerve stimulation (VNS) is known to be an effective palliative therapeutic alternative in the treatment of refractory epilepsy.
From precedent studies, VNS at high paradigm has been demonstrated more effective than at low paradigm. 29 Other studies 30 confirmed a long lasting effectiveness of VNS, increasing in years, with a 23% of 50% of seizure reduction at 3 months after stimulation onset, reaching 43% at 2 years and 3 months. Further data from different authors are VNS: outcome and electroclinical pattern 205 
Difference (D) in seizure frequency: =, D < 20%; "#, D20 ! 50%; ""##, D50 ! 75%; """###, D > 75%. 24 report 52% of seizure reduction after 12 years of stimulation, also Murphy 31 found a similar reduction in their group of patients. These percentages are almost the same reported in the whole literature, to date. 15, 22, 23, 25, 27 Only Binnie et al. 26 reported a lower number of responsive patients, probably due to the gravity of their patients. In every published study the indication is for partial pharmacoresistant epilepsies, while it does not appear to be an indication that addresses the ideal candidate for VNS implantation.
There is a noticeable paucity of reliable date on which kinds of seizures seem to be more responsive to the VNS therapy. Holmes et al. 22 do describe successful outcomes using VNS in the treatment of generalized seizures in patients having idiopathic or symptomatic generalized epilepsy with a significant reduction of seizures that involving a fall. But to our knowledge there are no studies that relate VNS success to the electrical patterns seen in responsive seizures.
In this study, we present the results of VNS in 17 patients with partial refractory epilepsy, 16 of which had experienced epileptic falls that seem to be due to a secondary synchronization of the focal ictal discharge. The patients we have reported on in this study have fallen down from different types of seizure activity: tonic, tonico-postural, atonic, although we were not able to obtain electrographic recordings during all these seizures.
If VNS achieves its effect by desynchronizing cerebral pathologic discharges, as has been suggested, 31 it might therefore be expected to counteract any diffuse discharges that lead to a fall or any secondary generalization. In our study, we observed our best outcomes with retropulsive tonic seizures and our worst outcomes with tonico-postural seizures. It is not easy to interpret this outcome, but tonico-postural seizures are focal frontal seizures determining a fall, and their location is, in our series, the less affected by VNS.
Our most successful results were observed in patients, whose ictal discharge involved at onset the temporal region and this was usually seen to occur when there was a very rapid diffusion. Patients with ictal frontal, central or diffuse discharges consistently were found to have the poorest results after VNS.
Data from PET studies done on patients with VNS indicates a decrease in synaptic activity in temporal structures 6 which may suggest a mechanism for this VNS reduction of seizure activity. Though our findings are consistent with this notion, the size of our study is by no means sufficient to validate this hypothesis, which needs a larger series of patients using EEG ictal studies.
Our findings, which indicate that VNS may be more effective in cryptogenic patients raises interesting questions with respect to symptomatic patients.
In particular, our patients with LNS did not show very good results from VNS which seems to contrasts significantly with much of the data that exists in the literature on epileptic encephalopathies and particularly on LNS. [32] [33] [34] [35] [36] [37] [38] [39] In these studies, the reduction of seizures in LNS is similar to that of other partial epilepsies, a reduction of 50% of total seizures is observed in almost 50% of patients. In only one study, 39 in five of the six children with LNS a reduction of 90% of seizures is shown, but this was not furtherly confirmed by other data. The implanted patients with LNS were all under 18, differently from our young adult patients having a much longer illness duration. A correlation between better response to VNS a higher intelligence levels was observed. 32, 34 Our patients, only three, had a clinically observed very low mental age.
For justifying the mean bad results of our series we think that this discrepancy may be due primarily to the criteria that have been used to identify candidates for VNS. In this study, we have only chosen patients who demonstrate very severe, long lasting, epilepsy and falling seizures who have been excluded from surgery or those who have been operated upon previously but unsuccessfully. In the other series that have been reported there is a noticeably higher variability in the duration and the severity of the epilepsy being studied. Falling seizures are known to be highly refractory to pharmacological therapy, 28 and our results with VNS seem to confirm the difficulty that exists in treating these seizures.
We therefore agree that VNS may be considered for patients whose epilepsy is refractory and unresponsive to surgical treatment, and suggest to study where the ictal discharges arise from. Our observation of ''temporal responders'' is limited to a very small series, but the reason why patients with focal temporal onset of ictal discharge could be the 'best' responders may be related to the fact that vagal efferents are directed to the temporal areas, possibly inhibiting epileptic discharges. More extensive studies on electrical ictal pattern of responsive patients may be able to lead to a more precise indication for VNS and to more satisfactory results with this promising therapeutic technique.
